Plasma proteomics identify biomarkers predicting Parkinson’s disease up to 7 years before symptom onset - Nature Communications
www.nature.com
Parkinson’s disease is lacking easily accessible biomarkers. Here the authors show, that targeted blood proteomics is feasible to identify the patients and to predict the phenoconvertion in prodromal subjects up to 7 years before symptom onset.
  • JimSamtanko@lemm.eeEnglish
    3·
    5 months ago

    Meanwhile, we’re finding out that many of the hotshot AI breakthroughs were oversold. Hopefully this is not going to be another disaster.